Pharma and Biotech
By Caoimhe Toman
Date: Monday 23 Apr 2018
LONDON (ShareCast) - (WebFG News) - Experian: Deutsche Bank upgrades to buy with a target price of 1,750p.
Just Eat: Berenberg reiterates buy with a target price of 840p.
AA plc: Berenberg reiterates sell with a target price of 65p.
Ashtead: Deutsche Bank reiterates hold.
Polypipe: Deutsche Bank reiterates buy.
WPP: Deutsche Bank reiterates hold.
Petrofac: Goldman Sachs reiterates buy with a target price of 674p.
Sage Group: Goldman Sachs reiterates buy with a target price of 780p.
Britvic: Citigroup reiterates buy with a target price of 870p.
Anglo American: Credit Suisse reiterates neutral with a target price of 1,720p.
Ferrexpo: Credit Suisse reiterates neutral with a target price of 230p.
Marks & Spencer: Credit Suisse upgrades to neutral with a target price of 285p.
RSA: Jefferies initiates at hold with a target price of 600p.
DMGT: Numis reiterates buy with a target price of 905p.
Polymetal: Numis reiterates buy with a target price of 1,100p.
Rotork: Numis reiterates hold with a target price of 300p.
River & Mercantile group: Canaccord reiterates buy with a target price of 365p.
Strix Group: Canaccord initiates at buy with a target price of 210p.
Beximco Pharmaceuticals: Northland Capital Markets reiterates buy with a target price of 75p.
Savannah Resources: Northland Capital Markets reiterates corporate.
Applegreen: Berenberg reiterates buy with a target price of 600p.
The Weir Group: RBC Capital Markets reiterates outperform with a target price of 2,600p.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Price | 40.33p |
Change Today | 0.33p |
% Change | 0.83 % |
52 Week High | 73.00p |
52 Week Low | 39.00p |
Volume | 1 |
Shares Issued | 100.04m |
Market Cap | £40.35m |
RiskGrade | 190 |
Latest | Previous | |
---|---|---|
Final | Final | |
Ex-Div | 14-Nov-17 | n/a |
Paid | 18-Jan-18 | n/a |
Amount | 1.25 | 0.50 |
Time | Volume / Share Price |
11:29 | 1 @ 39.00p |
Chair | Ahmed Sohail Fasiur Rahman |
You are here: research